Alvotech

NASDAQ:ALVO   1:00:00 PM EDT
9.19
+0.26 (+2.91%)
2:25:26 PM EDT: $9.16 -0.03 (-0.32%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)2.77B
Current PE28.73
Forward PE 43.76
2yr Forward PE 18.02
See more stats
Estimates Current Quarter
Revenue$120.51 Million
Adjusted EPS$0.00
See more estimates
10-Day MA$9.22
50-Day MA$9.60
200-Day MA$11.23
See more pivots

Alvotech Stock, NASDAQ:ALVO

9, rue de Bitbourg, 28th floor, Luxembourg, Luxembourg 1273
Luxembourg
Phone: +352.422.4500
Number of Employees: 1026

Description

Alvotech is a biotechnology company, which engages in the development and manufacture of biosimilar medicines. The firm is focusing on the development of its product candidates. It operates through the following geographical segments: Europe, North America, Asia, and Other. The company was founded by R�³bert Vilhelm Wessman in 2013 and is headquartered in Luxembourg.